JAZZ - Jazz Pharmaceuticals EPS beats by $0.51 beats on revenue November, 05 2019 04:07 PM Jazz Pharmaceuticals plc Jazz Pharmaceuticals (NASDAQ:JAZZ): Q3 Non-GAAP EPS of $4.10 beats by $0.51; GAAP EPS of $1.78 misses by $0.32.Revenue of $537.7M (+14.6% Y/Y) beats by $13.78M.Shares +5.6%.Press ReleaseMore news on: Jazz Pharmaceuticals plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news,